Wave Life Sciences Ltd Cash Flow Reinvestment Rate
Latest as of March 2023:
0.01x
Wave Life Sciences Ltd cash flow reinvestment rate. Wave Life Sciences Ltd (WVE) has a Cash Flow Reinvestment Rate of 0.01x as of March 2023, reinvesting $978.00K (capex $489.00K plus investments $-489.00K) from operating cash flow of $85.52 Million. Explore cash flow to debt ratio of Wave Life Sciences Ltd to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
0.01x
(Capex + Investments) / Operating CF
Total Reinvested
$978.00K
Capex + Investments
Operating Cash Flow
$85.52 Million
USD
Capital Expenditures
$489.00K
USD
Wave Life Sciences Ltd Cash Flow Reinvestment Rate by Year (None–None)
Wave Life Sciences Ltd cash flow reinvestment rate by year from None to None. Year-by-year capital reinvestment analysis for Wave Life Sciences Ltd. For the full cash flow conversion analysis, see Wave Life Sciences Ltd cash flow conversion.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow